Literature DB >> 21465146

Differential diagnosis of chorea.

Ruth H Walker1.   

Abstract

Chorea is a common movement disorder that can be caused by a large variety of structural, neurochemical (including pharmacologic), or metabolic disturbances to basal ganglia function, indicating the vulnerability of this brain region. The diagnosis is rarely indicated by the simple phenotypic appearance of chorea, and can be challenging, with many patients remaining undiagnosed. Clues to diagnosis may be found in the patient's family or medical history, on neurologic examination, or upon laboratory testing and neuroimaging. Increasingly, advances in genetic medicine are identifying new disorders and expanding the phenotype of recognized conditions. Although most therapies at present are supportive, correct diagnosis is essential for appropriate genetic counseling, and ultimately, for future molecular therapies.

Entities:  

Mesh:

Year:  2011        PMID: 21465146     DOI: 10.1007/s11910-011-0202-2

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  102 in total

1.  Phenomenology of "Lubag" or X-linked dystonia-parkinsonism.

Authors:  Virgilio Gerald H Evidente; Joel Advincula; Raymund Esteban; Paul Pasco; Jhoe Anthony Alfon; Filipinas F Natividad; Joven Cuanang; Amado San Luis; Katrina Gwinn-Hardy; John Hardy; Dena Hernandez; Andrew Singleton
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

2.  Karak syndrome: a novel degenerative disorder of the basal ganglia and cerebellum.

Authors:  A Mubaidin; E Roberts; D Hampshire; M Dehyyat; A Shurbaji; M Mubaidien; A Jamil; A Al-Din; A Kurdi; C G Woods
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

3.  Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies.

Authors:  P Krolak-Salmon; G Androdias; D Meyronet; M Aguera; J Honnorat; A Vighetto
Journal:  Eur J Neurol       Date:  2006-03       Impact factor: 6.089

4.  Adult-onset chorea and mitochondrial cytopathy.

Authors:  Morgane Caer; Karine Viala; Richard Levy; Thierry Maisonobe; Florence Chochon; Agnès Lombès; Yves Agid
Journal:  Mov Disord       Date:  2005-04       Impact factor: 10.338

5.  The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.

Authors:  D H Geschwind; S Perlman; C P Figueroa; L J Treiman; S M Pulst
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

6.  Primary Sjogren's syndrome presenting as a generalized chorea.

Authors:  P Venegas Fanchke; M Sinning; M Miranda
Journal:  Parkinsonism Relat Disord       Date:  2005-05       Impact factor: 4.891

7.  Severe generalised dystonia associated with a mosaic pattern of striatal gliosis.

Authors:  W R Gibb; L Kilford; C D Marsden
Journal:  Mov Disord       Date:  1992       Impact factor: 10.338

8.  Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency.

Authors:  Heiko Krude; Barbara Schütz; Heike Biebermann; Arpad von Moers; Dirk Schnabel; Heidi Neitzel; Holger Tönnies; Dagmar Weise; Antony Lafferty; Siegfried Schwarz; Mario DeFelice; Andreas von Deimling; Frank van Landeghem; Roberto DiLauro; Annette Grüters
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

9.  Acute methotrexate neurotoxicity with choreiform movements and focal neurological deficits: a case report.

Authors:  Daniela A Bota; Rima M Dafer
Journal:  South Med J       Date:  2009-10       Impact factor: 0.954

10.  Benign hereditary chorea: clinical, neuroimaging, and genetic findings.

Authors:  Muhammad Mahajnah; Dov Inbar; Adam Steinmetz; Peter Heutink; G J Breedveld; Rachel Straussberg
Journal:  J Child Neurol       Date:  2007-10       Impact factor: 1.987

View more
  15 in total

1.  Extrapyramidal examinations in psychiatry.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Innov Clin Neurosci       Date:  2012-07

Review 2.  Diagnosis and treatment of chorea syndromes.

Authors:  Andreas Hermann; Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

3.  Update on the Non-Huntington's Disease Choreas with Comments on the Current Nomenclature.

Authors:  Ruth H Walker
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-01-30

4.  Chorea associated with high titers of antiphospholipid antibodies in the absence of antiphospholipid antibody syndrome.

Authors:  Damoun Safarpour; Sarah Buckingham; Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-02-13

5.  Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders.

Authors:  Sidharth Mehan; Shaba Parveen; Sanjeev Kalra
Journal:  Neural Regen Res       Date:  2017-02       Impact factor: 5.135

6.  Cortical Stroke and Hemichorea.

Authors:  Konark Malhotra; Arjun Khunger
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-02-06

7.  Antiphospholipid-related chorea.

Authors:  Silvio Peluso; Antonella Antenora; Anna De Rosa; Alessandro Roca; Gennaro Maddaluno; Vincenzo Brescia Morra; Giuseppe De Michele
Journal:  Front Neurol       Date:  2012-10-22       Impact factor: 4.003

8.  Benign hereditary chorea, not only chorea: a family case presentation.

Authors:  Jeanette Koht; Sven Olav Løstegaard; Iselin Wedding; Marie Vidailhet; Malek Louha; Chantal Me Tallaksen
Journal:  Cerebellum Ataxias       Date:  2016-02-02

9.  P/Q and N-type Voltage-gated Calcium Channel Binding Antibodies Associated with Paraneoplastic Chorea and Mixed Invasive Ductal and Lobular Carcinoma of the Breasts in an Elderly Patient.

Authors:  Kevin Chang; Anita Lwanga; Tanjeev Kaur; Cathy Helgason
Journal:  Cureus       Date:  2018-08-04

Review 10.  Novel Imaging Biomarkers for Huntington's Disease and Other Hereditary Choreas.

Authors:  Patrik Fazio; Martin Paucar; Per Svenningsson; Andrea Varrone
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.